We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
PerkinElmer Inc | NYSE:PKI | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 115.24 | 0 | 01:00:00 |
DALLAS, Sept. 19, 2011 /PRNewswire/ -- Securities lawyers at Goldfarb Branham LLP are investigating whether board of directors of Caliper Life Sciences (NASDAQ: CALP) violated shareholder protection laws in its proposed buyout by PerkinElmer, Inc. (NASDAQ: PKI) for $10.50 per share. Concerned investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or hlindley@goldfarbbranham.com about their rights and remedies.
"The offer represents a premium of 42% for CALP shareholders, but the company reported on September 7, 2011 that it has $34 million as a result of organic growth, which is up 24% for the first half of the year. The buyout will result in a cash out for shareholders while CEO Robert F. Friel remains with the company," securities lawyer Hamilton Lindley said. "Our proposed class action lawsuit seeks to ensure that the investors received reasonable value and information in this buyout."
Goldfarb Branham LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. CALP investors – or anyone with knowledge about this acquisition – should contact lawyer Hamilton Lindley at
hlindley@goldfarbbranham.com or 877-583-2855.
Hamilton Lindley
Goldfarb Branham LLP
2501 N. Harwood, Ste. 1801
Dallas, TX 75201
(877) 583-2855 Toll Free Telephone
(214) 583-2233 Local Phone Number
(214) 583-2234 Fax Number
hlindley@goldfarbbranham.com
www.goldfarbbranham.com
SOURCE Goldfarb Branham LLP
Copyright 2011 PR Newswire
1 Year PerkinElmer Chart |
1 Month PerkinElmer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions